Sanofi (SNY) Invested Capital (2009 - 2026)

Sanofi has reported Invested Capital for 18 years, with the latest figure at $8.2 billion in Q2 2026.

• Quarterly Invested Capital fell 64.84% year-over-year to $8.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $29.9 billion (down 26.03% YoY) and the FY2025 annual result came in at $21.8 billion, up 26.25% from the prior year.
• Invested Capital fell to $8.2 billion in Q2 2026 per SNY's latest filing, from $21.8 billion in the prior quarter.
• Over five years, Invested Capital peaked at $23.6 billion in Q2 2024 and troughed at $8.2 billion in Q2 2026.
• A 5-year average of $19.2 billion and a median of $20.5 billion in 2022 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2025: Invested Capital tumbled 79.07% in 2022, then rose 26.25% in 2025.
• Over 5 years, Invested Capital stood at $19.6 billion in 2022, then declined by 9.29% to $17.8 billion in 2023, then retreated by 3.05% to $17.2 billion in 2024, then grew by 26.25% to $21.8 billion in 2025, then plunged by 62.49% to $8.2 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $8.2 billion, $21.8 billion, and $23.2 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.